Navigation Links
Efficient Transfection of Neurospora Crassa

Katherine A. Borkovich PhD and Kimberly Vollmer
Katherine A. Borkovich PhD, University of Texas-Houston Medical Center,
Dept. of Microbiology and Molecular Genetics, Houston, Texas.
Kimberly Vollmer, Brinkmann™ Instruments Inc., BioSystems Application Lab, Westbury, New York. INTRODUCTION:

The diverse reproductive capabilities and the nutritional conventions of Neurospora crassa have made this filamentous fungus a model organism in the field of molecular biology and genetics for more than a half a century. In fact, N. crassa was used in the Nobel Prize-winning "One-gene One-enzyme" theory [1]. Since then, N. crassa has been used as a model organism in other types of molecular and genetic applications, joining the illustrious company of E. coli and Drosphila melanogaster.

Perhaps one of the most important roles forN. crassa has been as a host organism for exogenous DNA. Over the years, several techniques have been developed to introduce exogenous material into cells. Electroporation, a technique utilizing electronically regulated pulses to open the cellular membrane and introduce material, has become an easy and efficient method of transfection.

The Eppendorf® Electroporator 2510 employs electric pulse technology to provide an easy and efficient means of introducing exogenous DNA into N. crassa conidia [2]. Most procedures in the past have either used protoplasts for the transfection of N. crassa, or have required the addition of an enzyme to facilitate the weakening of the cell wall. When using the Electroporator 2510, germinated conidia can
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
2. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
3. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
4. Efficient Transfection of Neurospora Crassa
5. Efficient Recovery of Ultrapure Plasmid DNA
6. Efficient and Reliable PCR Setup Using Eppendorf MasterMix
7. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
8. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
9. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
10. Efficient and Reliable Linear Amplification of cRNA
11. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Efficient Transfection Neurospora Crassa

(Date:11/20/2009)...O, Nov. 20 Veridiam (www.veridiam....size company category at the 2009 Workplace Excell...iego Society for Human Resources Management and re... practices. ,, Veridiam was one of nine winners...ompanies, honored at the recent awards ceremony. S...
(Date:11/20/2009)...TLE, Nov. 20 Cell Therap...d today that the Ninth Circuit Court of Appeals re...CTI should be allowed to pursue all of its claims ...he District Court for trial. CTI filed a complain... reimbursement consultant for CTI,s product TRISEN...
(Date:11/19/2009)...N, Nov. 19 Danish Prince Joachim i...ethanol plant in Kalundborg, Denmark, on Wednesday...first and largest 2nd generation ethanol demonstra... are used in the plant,s innovative process for co...nisco, was the first to market with commercial enz...
(Date:11/19/2009)..., Nov. 19 NeoStem, Inc. ...nt the following letter to its shareholders, discu...09, of China Biopharmaceuticals Holdings, Inc. (CH...d in the People,s Republic of China. The merger gi...yre Pharmaceutical Co. Ltd., CHBP,s primary operat...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...mproved Technology Will Provide the Early Detectio...in Fish Farms and Wild Stocks -, HAMILTON, New Ze...une,17 ZyGEM Corp Ltd. and DIAGNOTEC S.A. today a...oduce molecular diagnostics for the,detection of i...ly pathogen,that attacks salmon and other fish spe...
...h Throughput Technology Identifies DNA Variations ... and Test Genome, OMAHA, Neb., June 17 Transgeno...t it is developing SURVEYOR,Endonuclease Adaptor-l...,throughput enabling technology for whole genome a...reference genome and a test genome. SEAL is,design...
...VER, June 17 Corgenix Medical Corporation,(OTC Bu...keter of,diagnostic test kits, announced today the...Charles H. Miranda, M.D., F.A.C.P., F.A.A.P., to i...nda join Luis Lopez, M.D., Corgenix Chairman and,C...ntific advisory board,members to three., "These t...
Other Biology Technology:ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon 2ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon 3Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 2Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 3Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 4Corgenix Expands Scientific Advisory Board 2Corgenix Expands Scientific Advisory Board 3
(Date:11/20/2009)...November 19, 2009 The estimated 4.6 million Ameri...k of developing respiratory symptoms due to poor a...naire study undertaken earlier this year by invest...eterinary Medicine. , The studywhich polled more...50 percent of individuals working in barns complai...
(Date:11/20/2009)...able in German . , In the current online is.... Stefanie Eyerich and Dr. Kilian Eyerich together...n and Istituto Dermopatico dell,Immacolata in Rome...sents a milestone on the way to developing new tre... as psoriasis and allergic reactions and potential...
(Date:11/20/2009)...new study, researchers report that a class of hear...ful, or harmful, effect on the heart, depending on...pears in the journal Circulation Research , found...d beta-receptors on the heart muscle offer the mos...rget only the beta-receptors can actually undermin...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2American Dental Association Web Survey Offers Chance at 24150 Gift Certificate 54263 1American Dental Association Web Survey Offers Chance at 24150 Gift Certificate 54263 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 1Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 4Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 5Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 6Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 7Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 8Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3
...lot-dissolving medication that is administered to ...ay help to reduce the risk of amputation following...ne issue of Archives of Surgery, one of the JAMA/A...ed essentially the same for the past 25 years, acc...Today, traditional therapy consists of tissue rewa...
...at the University of Central Florida is proving pr...ucoma, an eye disease that can cause blindness and...particle can safely get past the blood-brain barri...delivery,” said Sudipta Seal, an engineering profe... Processing and Analysis Center and the Nanoscienc...
...ions and other diseases of the brain is the blood-...ed therapeutic drugs from reaching the brain. Gran...ctious Diseases, part of the National Institutes o...tide) from the rabies virus can carry a strip of t... administration. Once delivered to the nerve cells...
Other Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2UCF nanoparticle offers promise for treating glaucoma 2Blood-brain barrier breached by new therapeutic strategy 2
Rat Anti-Mouse Axl Monoclonal Antibody, Unconjugated, Clone 175128 from R&D Systems
Rabbit Anti-Human RXRA Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Human M-CSF from BioVision
Mouse Anti-Human IL-19 Monoclonal Antibody, Unconjugated, Clone 152112 from R&D Systems
Biology Products: